Ocugen, Inc. current report, 13 June 2017

Full document

Business Context and Reporting Period

This Form 8-K filing by Histogenics Corporation (noting the metadata reference to Ocugen, Inc. appears to be a discrepancy as the filing text explicitly names Histogenics) reports on the results of the 2017 Annual Meeting of Stockholders held on June 13, 2017. The company is incorporated in Delaware and is classified as an emerging growth company.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.

Material Changes and Voting Results

Of the 22,168,090 shares entitled to vote, 19,131,296 shares (approximately 86.3%) were represented, constituting a quorum. Two proposals were submitted and approved:

  • Proposal 1 (Election of Directors): Stockholders elected three Class III directors (David Gill, John H. Johnson, and Garheng Kong, M.D., Ph.D.) for a three-year term. Each director received approximately 14.99 million votes "For" with roughly 285,000 to 286,000 votes "Withheld."
  • Proposal 2 (Ratification of Auditors): Stockholders ratified the selection of Grant Thornton LLP as the independent registered public accounting firm. The vote was 19,112,883 "For," 15,269 "Against," and 3,144 "Abstaining."

Guidance, Outlook, and Risks

The filing text does not provide a clear value for future guidance, management commentary on outlook, specific risks, contingencies, or unusual items. The document serves strictly as a disclosure of the annual meeting vote tallies.

Important Facts for Investors to Verify

  • Verify the corporate identity discrepancy between the metadata (Ocugen, Inc.) and the filing text (Histogenics Corporation).
  • Confirm the tenure of the newly elected Class III directors, which extends until the 2020 annual meeting.
  • Review the definitive proxy statement filed on April 27, 2017, for detailed background on the director nominees and auditor selection.
  • Note the high level of broker non-votes (3,850,963) regarding the election of directors.